What's New

Last Posted: Jun 02, 2023

• Genetically adjusted PSA levels for prostate cancer screening.
  Linda Kachuri et al. Nat Med 2023 6
• Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis.
  Tim M Govers et al. World J Urol 2023
• Genomic classifier performance in intermediate-risk prostate cancer: Results from NRG Oncology/RTOG 0126 randomized phase III trial.
  Daniel E Spratt et al. Int J Radiat Oncol Biol Phys 2023
• An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study.
  Magdalena Görtz et al. Digit Health 2023 920552076231173304
• Application of machine learning algorithm in prediction of lymph node metastasis in patients with intermediate and high-risk prostate cancer.
  Xiangrong Wang et al. J Cancer Res Clin Oncol 2023
• FastMRI Prostate: A Publicly Available, Biparametric MRI Dataset to Advance Machine Learning for Prostate Cancer Imaging.
  Radhika Tibrewala et al. ArXiv 2023
• Acting on Actionable Mutations in Metastatic Prostate Cancer.
  Catherine H Marshall et al. J Clin Oncol 2023 JCO2300350
• Attitudes, Perceptions, and Use of Cancer-based Genetic Testing Among Healthy U.S. Adults and Those With Prostate or Breast/Ovarian Cancer.
  Sameer Thakker et al. Urol Pract 2023 10(1) 26-32
• Clinical utility of polygenic risk scores: a critical 2023 appraisal
  S Koch et al, J Comm Genetics, May 3, 2023
• Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Incidence of Depression Among Older Cancer Survivors With Osteoarthritis: A Machine Learning Analysis.
  Nazneen Fatima Shaikh et al. Cancer Inform 2023 2211769351231165161
• Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
  Gillian S Dite et al. Prostate 2023
• Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy.
  Shinpei Saito et al. Sci Rep 13(1) 6325
• Toward Precision Medicine: Development and Validation of A Machine Learning Based Decision Support System for Optimal Sequencing in Castration-Resistant Prostate Cancer.
  Hakyung Lim et al. Clin Genitourin Cancer
• Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning.
  Anouk C de Jong et al. Nature communications 2023 4 (1) 1968
• Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
  Kelsey E Breen et al. The Journal of urology 2023 101097JU0000000000003186
• Interactions of SNPs in Folate Metabolism Related Genes on Prostate Cancer Aggressiveness in European Americans and African Americans.
  Hui-Yi Lin et al. Cancers 2023 15(6)
• Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.
  Kunzah Jamal et al. Cancer research communications 2023 2(10) 1244-1254
• Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
  Pengfei Jin et al. BMC medical imaging 2023 23(1) 47
• Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
  Christine M Gunn et al. Cancer control : journal of the Moffitt Cancer Center 2023 3010732748221143884
• Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome.
  Clara Cerrato et al. World journal of urology 2023
• Deep learning enables MV-based real-time image guided radiation therapy for prostate cancer patients.
  Danielle Maria Chrystall et al. Physics in medicine and biology 2023
• Virtual clinical trial based on outcome modeling with iteratively redistributed extrapolation data.
  Kohei Oguma et al. Radiological physics and technology 2023
• Convolutional Neural Network Quantification of Gleason Pattern 4 and Association with Biochemical Recurrence in Intermediate Grade Prostate Tumors.
  Yalei Chen et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 100157
• Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
  Michael Baboudjian et al. World journal of urology 2023
• Are population level familial risks and germline genetics meeting each other?
  Kari Hemminki et al. Hereditary cancer in clinical practice 2023 21(1) 3
• Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
  Lauren G Santos et al. JAMA network open 2023 6(3) e231723
• The role of community health advisors' cancer history in implementation and efficacy of a cancer control intervention.
  Maisha R Huq et al. Health education research 2023
• Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
  Shaoxu Wu et al. The Lancet. Oncology 2023
• Label Distribution Learning for Automatic Cancer Grading of Histopathological Images of Prostate Cancer.
  Mizuho Nishio et al. Cancers 2023 15(5)
• A Polygenic Risk Score for Prostate Cancer Risk Prediction.
  Kerry R Schaffer et al. JAMA internal medicine 2023 3

More